| PERIOD ENDING | 3-Jan-09 | 29-Dec-07 | 30-Dec-06 | | Total Revenue | 486,896 | 471,336 | 411,306 | | Cost of Revenue | 352,967 | 323,316 | 297,053 | | | Gross Profit | 133,929 | 148,020 | 114,253 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 53,595 | 61,366 | 53,031 | | Non Recurring |
-
|
-
| (525) | | Others | 6,450 | 5,501 | 731 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 73,884 | 81,153 | 61,016 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| | Earnings Before Interest And Taxes | 73,884 | 81,153 | 61,016 | | Interest Expense | 58,067 | 52,688 | 43,481 | | Income Before Tax | 15,817 | 28,465 | 17,535 | | Income Tax Expense | 6,084 | 10,640 | 5,962 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 9,733 | 17,825 | 11,573 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 9,733 | 17,825 | 11,573 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $9,733 | $17,825 | $11,573 |
|
0.83% Nasdaq 
Income Statement
